Step Pharma Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2ndary - Private
- Investors
-
9
Step Pharma General Information
Description
Developer of proprietary small molecule therapeutics designed for the treatment of auto-immune diseases. The company's therapeutics use a novel class of oral nucleotide synthesis inhibitors that can target CTPS1 (cytidine triphosphate synthase 1) to induce selective modulation of specific immune cell populations such as T and B cells, translating to better efficacy and an improved therapeutic index, enabling healthcare providers in proper treatment of auto-immune diseases.
Contact Information
Website
www.step-ph.comCorporate Office
- 15 Rue Louis and Auguste Lumière
- Technoparc du Pays-de-Gex
- 01630 Saint-Genis-Pouilly
- France
Corporate Office
- 15 Rue Louis and Auguste Lumière
- Technoparc du Pays-de-Gex
- 01630 Saint-Genis-Pouilly
- France
Step Pharma Timeline
Step Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-Jul-2021 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC (Series B) | 24-Mar-2021 | Completed | Pre-Clinical Trials | |||
| 6. Early Stage VC | 16-Dec-2018 | Completed | Pre-Clinical Trials | |||
| 5. Early Stage VC (Series A) | 21-Nov-2017 | Completed | Startup | |||
| 4. Early Stage VC | 28-Jul-2015 | Completed | Startup | |||
| 3. Accelerator/Incubator | 24-Nov-2014 | Completed | Startup | |||
| 2. Seed Round | 30-Jul-2014 | $3.39M | $3.39M | Completed | Startup | |
| 1. Joint Venture | Completed | Startup |
Step Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| BSA-T4 | ||||||||
| BSA-T3 | ||||||||
| BSA-T2 | ||||||||
| ADP B | ||||||||
| Category B Preference | ||||||||
| Ordinary | ||||||||
| Series A | ||||||||
| Series A | 2,935,873 | $0.119842 | $2.4 | $2.4 | 1x | $2.4 | 12.14% | |
| Ordinary | 1,250,000 | $0.119842 | $2.4 | $2.4 | 1x | $2.4 | 5.17% |
Step Pharma Comparisons
Industry
Financing
Details
Step Pharma Competitors (52)
One of Step Pharma’s 52 competitors is NexImmune, a Formerly VC-backed company based in Gaithersburg, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
| Gadeta | Formerly VC-backed | Utrecht, Netherlands | ||||
| Adimab | Venture Capital-Backed | Lebanon, NH | ||||
| Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA |
Step Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Step Pharma Patents
Step Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023228045-A1 | Combinations of ctps1 and bcl2 inhibitors for cancer | Pending | 01-Mar-2022 | ||
| EP-4041723-A2 | Sulfonamide derivatives as ctps1 inhibitors | Pending | 20-Sep-2019 | ||
| US-20230002352-A1 | Sulfonamide derivatives as ctps1 inhibitors | Pending | 20-Sep-2019 | ||
| US-20230020663-A1 | Sulfonamide inhibitors as ctps1 inhibitors | Pending | 20-Sep-2019 | ||
| EP-4041715-A1 | Sulfonamide inhibitors as ctps 1 inhibitors | Pending | 20-Sep-2019 | C07D401/12 |
Step Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Step Pharma Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hadean Ventures | Venture Capital | Minority | ||
| Sunstone Life Science Ventures | Venture Capital | Minority | ||
| Imagine Institute | Corporation | Minority | ||
| Pontifax Venture Capital | Venture Capital | Minority | ||
| Sygnature Discovery | PE-Backed Company | Minority |
Step Pharma FAQs
-
When was Step Pharma founded?
Step Pharma was founded in 2014.
-
Where is Step Pharma headquartered?
Step Pharma is headquartered in Saint-Genis-Pouilly, France.
-
What is the size of Step Pharma?
Step Pharma has 12 total employees.
-
What industry is Step Pharma in?
Step Pharma’s primary industry is Drug Discovery.
-
Is Step Pharma a private or public company?
Step Pharma is a Private company.
-
What is Step Pharma’s current revenue?
The current revenue for Step Pharma is .
-
How much funding has Step Pharma raised over time?
Step Pharma has raised $67.5M.
-
Who are Step Pharma’s investors?
Hadean Ventures, Sunstone Life Science Ventures, Imagine Institute, Pontifax Venture Capital, and Sygnature Discovery are 5 of 9 investors who have invested in Step Pharma.
-
Who are Step Pharma’s competitors?
NexImmune, Gadeta, Adimab, Carisma Therapeutics, and Kite Pharma are some of the 52 competitors of Step Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
